Graph not available
Graph not available

Open Demat Account

50years
50 Years
of Trust & Legacy
₹0 AMC
for First Year
₹0 Brokerage
on Delivery, Intraday, Currency and NSE F&O
left-arrow
Fundamentals
Financials
Shareholding
Resistance/Support
Delivery and Volume
About
Management
News
Similar Stocks
right-arrow

Zim Laboratories Ltd Performance

Today's Low
112.00
arrowIcon
Today's High
116.85
52 Wk Low
74.70
arrowIcon
52 Wk High
152.70


Open

112.25

Traded Value (Cr)

2.56 Cr

Prev. Close

111.9

VWAP

113.87

Volume

1,28,072

Face Value

10

Zim Laboratories Ltd Fundamentals

Market Cap
₹ 572 Cr
P/E Ratio (TTM)
34.84
P/B Ratio
2.53
Debt to Equity
0.27
ROE
8.06 %
EPS (TTM)
3.37
Dividend Yield
0.00%
Book Value
46.38

Click here to know more about Fundamentals

Zim Laboratories Ltd Financials

Zim Laboratories Ltd Financials

Zim Laboratories Ltd Shareholding Pattern

Held By Mar 2024 Dec 2023 Sep 2023 Jun 2023
Retail 49.01 % 50.92 % 50.74 % 49.90 %
Promoters 33.26 % 33.26 % 33.26 % 33.26 %
Others 17.72 % 15.82 % 15.99 % 16.78 %
FII 0.01 % 0.00 % 0.00 % 0.06 %
Mutual Funds 0.00 % 0.00 % 0.00 % 0.00 %

Retail

49.01%

Promoters

33.26%

Others

17.72%

FII

0.01%

Mutual Funds

0.00%

Retail

50.92%

Promoters

33.26%

Others

15.82%

FII

0.00%

Mutual Funds

0.00%

Retail

50.74%

Promoters

33.26%

Others

15.99%

FII

0.00%

Mutual Funds

0.00%

Retail

49.90%

Promoters

33.26%

Others

16.78%

FII

0.06%

Mutual Funds

0.00%

Resistance and Support

₹116.22

PIVOT

resistance-arrow
Resistance
First Resistance₹118.733
Second Resistance₹122.417
Third Resistance₹124.933
support-arrow
Support
First Resistance₹112.533
Second Resistance₹110.017
Third Resistance₹106.333
RSI64.336
MACD10.800
ADX45.026
CCI18.297

Delivery and Volume

PeriodDelivery Volume Traded Volume Delivery Volume %
Day128,07281,20163.40
Week275,705160,94861.46
1 Month780,349312,14962.76
6 Months266,069157,93259.36

About Zim Laboratories Ltd

Zim Laboratories Ltd was incorporated in February, 1984 under the name and style of Zim Laboratories Private Limited in the State of Maharashtra. The Company became a Public Limited Company through fresh Certificate of Incorporation issued by the Registrar of Companies, Maharashtra, Mumbai. The Company is engaged in the manufacturing of formulation on drugs and pre formulation ingredients in India and marketing and selling these within and outside India. The Pharma Industry is dominated by Multinationals, Large Indian companies and in the lower end of the market large number of units mainly in the SSI sector. During the year 2019-20, ZIM Health Technologies Limited was acquired thereby resulting as a wholly owned subsidiary of the company . SIA ZIM Laboratories Limited got incorporated as a wholly owned subsidiary in Latvia. In 2023, the Company launched Thinoral (Patented Oral Thin Film technology) as an alternate drug delivery platform across RoW/ Pharmerging Markets and EU.

Managing Director

Anwar S Daud

Founded

1984

NSE Symbol

ZIMLAB

Zim Laboratories Ltd Management

NameDesignation
Anwar S DaudChairman & Managing Director
Zulfiquar M KamalDirector (Finance)
Prakash SapkalDirector (Operation)
Niraj DhadiwalDirector (Business Developmnt)
Kavita LoyaNon-Exec. & Independent Dir.
Padmakar JoshiNon-Exec. & Independent Dir.
Piyush NikhadiCompany Sec. & Compli. Officer
Kamlesh ShendeIndependent Director
Kakasaheb MahadikIndependent Director

Zim Laboratories Ltd News

Zim Laboratories to conduct board meeting
On 13 May 2024
Zim Laboratories consolidated net profit declines 27.58% in the December 2023 quarter
Sales decline 4.64% to Rs 96.29 crore
Zim Laboratories to convene board meeting
On 29 January 2024
Zim Laboratories to conduct board meeting
On 23 December 2023
Zim Laboratories consolidated net profit declines 23.85% in the September 2023 quarter
Sales decline 13.65% to Rs 85.83 crore
Zim Laboratories schedules board meeting
On 1 November 2023
Zim Laboratories consolidated net profit declines 95.53% in the June 2023 quarter
Sales decline 27.29% to Rs 67.44 crore
Zim Laboratories reports standalone net loss of Rs 0.14 crore in the June 2023 quarter
Sales decline 27.56% to Rs 67.01 crore
Zim Laboratories to conduct board meeting
On 14 August 2023
Zim Laboratories to hold AGM
On 10 July 2023

Similar Stocks

CompanyMarket CapMarket PriceP/E Ratio
SUNPHARMA₹ 3,58,616 Cr
₹ 1,506.55
(0.80 %)
86.97
CIPLA₹ 1,09,708 Cr
₹ 1,339.55
(-1.42 %)
33.36
DIVISLAB₹ 1,00,611 Cr
₹ 3,793.50
(0.09 %)
73.75
DRREDDY₹ 98,044 Cr
₹ 5,921.00
(0.74 %)
22.59
ZYDUSLIFE₹ 97,423 Cr
₹ 982.15
(1.44 %)
36.23

Zim Laboratories Ltd FAQ

By opening a demat account and having your KYC papers confirmed online, you may simply purchase Zim Laboratories Ltd shares in BlinkX

The share price of any stock is volatile and changes during the day due to a variety of variables. Zim Laboratories Ltd's share price is ₹115.05 as of May 10, 2024

Zim Laboratories Ltd's P/E ratio is 34.84 times as of May 10, 2024.

Zim Laboratories Ltd's most recent financial reports indicate a price-to-book ratio of 2.53, showing the company's stock market valuation in relation to the value of its real assets.

Market capitalisation, often known as market cap, is the market value of all outstanding shares of a publicly listed corporation. Zim Laboratories Ltd's market is 572 Cr as on May 10, 2024.

The current financial records of Zim Laboratories Ltd show a 8.06% ROE, showing great financial performance and effective capital utilisation, making it a significant statistic for investors.

The 52-week high/low price of a Zim Laboratories Ltd stock is the highest and lowest price at which it has traded over that period (about one year) and is used as a technical indicator. Zim Laboratories Ltd's 52-week high and low as of May 10, 2024 are ₹116.85 and ₹112 respectively.

As of the Mar 2024 quarter, the promoter shareholding in Zim Laboratories Ltd stands at 33.26%. During the same period, Institutional Investors have shown a slight increase in their holdings, rising from 0.00% to 0.01%.